Evidence map›Paper›PMID 27991544›Full record

ArticleScientific reports2016

Transcriptomic profiling of microglia reveals signatures of cell activation and immune response, during experimental cerebral malaria.

Barbara Capuccini, Jingwen Lin, Carlos Talavera-López, Shahid M Khan, Jan Sodenkamp, Roberta Spaccapelo, Jean Langhorne

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
2.7field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 53 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. CXCL10CNS neuroscience & therapeutics · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 3 countries.

Barbara CapucciniThe Francis Crick Institute, London NW1 1AT, UK.
Jingwen LinThe Francis Crick Institute, London NW1 1AT, UK.
Carlos Talavera-LópezThe Francis Crick Institute, London NW1 1AT, UK.
Shahid M KhanLeiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, Netherlands.
Jan SodenkampThe Francis Crick Institute, London NW1 1AT, UK.
Roberta SpaccapeloDepartment of Experimental Medicine, University of Perugia, 06132 Perugia, Italy.
Jean LanghorneThe Francis Crick Institute, London NW1 1AT, UK.
The Francis Crick Institute · GBLeiden University Medical Center · NLUniversity of Perugia · IT

Funding

Cancer Research UKMedical Research Council U117584248Wellcome Trust
6 · The paper itself

Abstract

Cerebral malaria is a pathology involving inflammation in the brain. There are many immune cell types activated during this process, but there is little information on the response of microglia, in this severe complication. We examined microglia by genome wide transcriptomic analysis in a model of experimental cerebral malaria (ECM), in which C57BL/6 mice are infected with Plasmodium berghei ANKA. Thousands of transcripts were differentially expressed in microglia at two different time points during infection. Proliferation of microglia was a dominant feature before the onset of ECM, and supporting this, we observed an increase in numbers of these cells in the brain. When cerebral malaria symptoms were manifest, genes involved in immune responses and chemokine production were upregulated, which were possibly driven by Type I Interferon. Consistent with this hypothesis, in vitro culture of a microglial cell line with Interferon-β, but not infected red blood cells, resulted in production of several of the chemokines shown to be upregulated in the gene expression analysis. It appears that these responses are associated with ECM, as microglia from mice infected with a mutant P. berghei parasite (ΔDPAP3), which does not cause ECM, did not show the same level of activation or proliferation.

Indexed as

2',5'-Oligoadenylate SynthetaseAnimalsCell ProliferationCells, CulturedChemokinesCluster AnalysisDisease Models, AnimalErythrocytesFemaleGene Expression ProfilingHistocompatibility Antigens Class IInterferon-betaInterferon Regulatory Factor-7Interferon Type IMalaria, CerebralMice2',5'-Oligoadenylate SynthetaseChemokinesHistocompatibility Antigens Class IInterferon-betaInterferon Regulatory Factor-7Interferon Type IIrf7 protein, mouseOasl1 protein, mouse

Identifiers

PMID27991544
PMCPMC5171943
OpenAlexW2563034783

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.